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The mechanisms of the synthesis of mammalian selenocysteyl-(Sty)-tRNA were studied using [%e]H2Se. HI% was prepared from [“Se]selenite, 
glutathione. NADPH and glutathione rcductase, and was purified by chromatography. It was confirmed that this I!& was a Se donor in the 
reaction of the synthesis of Sty-tRNA. [‘%e]Scy, liberated from aminoacyl-tRNA, was analyzed by TLC on silica gel an subsequent. autorpdiog 
raphy. The activity of Sty-tRNA synthesis was found in the supernatant at 10.5 000 x g of the murine liver extract, but not in the precipitate. The 
supernatant was chromatographed on DEAE-cellulose, and the activity was eluted at a concentration of 0.17 M KCI. This position is at the front 
shoulder of the peak of seryl-tRNA synthctase which was eluted at 0.20 M KCI. Major serinc tRNA IGA is not a substrate on which to synthesize 
Sty-tRNA, but natural opal suppressor serine IRNA is. On a chromatograph’- abpattern of a Sty-tRNA preparation OF. Sephacry! S-200. the 
radioactivity of “Se was clutcd at the tRNA peak. This showed that Sty bound to tRNA. The active protein fraction from DEAE-cellulose did 
not contain tRNA kinase, therefore Sty-tRNA must be directly synthesized from scryl-tRNA, not through phosphoseryl-tRNA. This mechanism 
is similar to that seen in Escherichiu co/i [1991, J. Biol. Chem. 266. 63241. 
Selenocysteine, tRNA; Selenium. tRNA: tRNA, opal suppressor: tRNA, serine; tRNA. selenocysteine; selenocysteine synthase 
1. INTRODUCTION 
Selenocysteine (Sty) is contained in mammalian glu- 
tathione peroxidase (GSHPx) [l] and type-l iodothyro- 
nine deiodinase [2]. Sty plays an important role at those 
active sites. The codon of Sty is UGA, which is nor- 
mally used as an opal termination codon in protein 
synthesis [2,3]. The natura1 tRNA corresponding to 
UGA is called opal suppressor tRNA and accepts serine 
[4]. This tRNA is present in the cytosol as Sty-tRNA 
in vivo [5]. The carbon skeleton of Sty in GSHPx comes 
from serine [6]. Meanwhiie, this suppressor seryl-tRNA 
is phosphorylated by tRNA kinasc to become phospho- 
seryl(Ps)-tRNA [7]. It has been presumed that Sty in 
mammals is biosynthesized on seryl-tRNA by conver- 
sion of the serine moiety to an intermediate, Ps-tRNA 
[S&9]. However, the mechanisms in mammals are am- 
biguous because the activity of Sty-tRNA synthesis has 
not been clarified. Meanwhile, in E. co/i the products of 
the se/,4 and se/D genes function in the biosynthesis of 
Sty-tRNA [lo]. SELA catalyzes the conversion of seryl- 
tRNA into Sty-tRNA, and SELD is involved in sele- 
nium metabolism [lo]. In order to clarify the mecha- 
nisms of the biosynthesis of mammalian Sty-tRNA? we 
searched for [75Se]Scy-tRNA synthesis activity in mu- 
rine liver extracts, and we show in this report that HSe 
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(H,Se is present as HSe- in buffers at neutral pH) is a 
Se donor in the synthesis of Sty-tRNA. 
2. EXPERIMENTAL 
Natural opal suppressor tRNA was prepared from bovine liver and 
chromatographed on BD-cellulose [I I]. The last fraction eluted from 
BD-cellulose is rich in suppressor tRNA and separated from major 
serine tRNA. This fraction was used for the assay of a Sty-tRNA 
synthesis reaction. The serine acceptor activity of this fraction was a 
20 pmol/A,,, unit. Assays of the scryl-tRNA synthetase (SerRS) of 
molecular mass 65.5 kDa and tRNA kinase were performed according 
to the method in [12]. 
The enzyme of Sty-tRNA synthesis was prepared from murine liver 
of the ICR strain as follows. Liver was minced with quartz sand in five 
volumes of0.25 M sucrose, 10 mM Tris-HCI, 10 mM mercaptoethanol 
at pH 7.5. This was centrifuged at 8000 x g for 10 min, and the 
supernatant was centrifuged at 105 000 x g for 60 min. The super- 
natant was chromatographed on a DEAE-cellulose column. 
Chromatographic conditions on DEAE-cellulose and Sephacryl S-300 
wcrc the same as in a previous report [12]. The activity of ScrRS in 
each eluate was measured in a similar manner as in [12]. The activity 
of Sty synthase was measured by a method that will be described later. 
The active fraction of Sty synthase was dialyzed against 50% glycerol, 
10 mM Tris-HCI, 10 mM MgCI,, IO mM mercaptoethanol at pH 7.5, 
and the daily yield was stored at -80°C. 
[‘%c]HSc- was prepared from [‘“Se]selenite by the enzymatic 
method of Ganther [13], as follows. [‘%]Selenite (I pl, 280 GBql 
mmol, 370 MBq/ml) was mixed with 10~1 of40 mM GSHI IpI of 10 
mM NADPH, 5 ~1 of 0.2 M mercaptoethanol, 5~1 of water, 2~1 of 
I M HEPES-NaOH (pH 7.5), and 0.25 ,uI of yeast GSH reduc:ase (a 
product of Boehringer). This mixture (‘H,Sc mixture’) was incubated 
overnight, and was used in preliminary experiments. For further exper- 
imcnts, HSe- was purified from the above ‘H&Z mixture’ by chroma- 
tography on Sephacryl S-200 in 10 mM mercaptoethanol. 10 mM 
acctatc at pH 4.6. The radioactivity of [“Se] in the cluatcs from the 
S-200 column was measured by a y-autowell counter (Aloka ARC 
301). Subsequently. eluatcs were ana!yzed by TLC as will be described 
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Fig. I. Autoradiograph of ‘?Se on TLC plates. The hydrolyzatc of 
[‘JSe]aminoacyl-tRNA was chromatographed on silica gel G. A, the 
enzyme preparation employed for Sty-tRNA synthesis was the preci- 
pitate at 105 Z.X x g of murine liver extracts; B. the enzyme was the 
supematant at 105 000 x g. Arrows indicate the position of authentic 
sty. 
later. The fractions containing HSc- were pooled and used for the 
reaction of the synthesis of Sty-tRNA. Authentic cold HSe- was chem- 
ically prcparcd according to the method described in reference (141. 
Sty synthase reaction WdS carried out as follows: suppressor tRNA 
(0.5 pmol) in 20~1 of 0.2 M HEPES at pH 7.4,20 mM MgCI:. 20 mM 
KCI, 20 mM mercaptoethanol was mixed with 1 ,uI of 40 mM scrine. 
5 ~1 of 50 mM ATP and 1~1 of SerRS. This was incubated for 20 min 
at 30°C. Afterwards. 10 pl (60 kBq) of I.2 ,uM HSe- and IO ~1 of 
enzyme preparation for Sty-tRNA synthesis were added to the mix- 
ture and were further incubated for 2 h at 30°C. After the incubation, 
the tRNA was precipitated by an addition of ethanol and was collec- 
ted. Part of this tRNA was chromatographcd on Sephacryl S-200 in 
0.15 M NaCI, IO mM acetate, IO mM mercaptoethanol (pH 4.6). The 
precipitate was washed with ethanol and then hydrolyzed in 5 ,ul of 
I M ammonium hydroxide solution in the presence of I M mcrcapto- 
ethanol for 2 h at 30°C. Mercaptoethanol was added to protect the 
Sty from oxidation. After the hydrolysis, the tRNA was precipitated 
by the addition of ethanol. and the supematant was immediately 
analyzed by TLC on silica gel G plates. Cold Sty (a generous gift of 
Prof. K. Soda of Kyoto University) was co-chromatographed. We 
confirmed that Sty was only slightly oxidized during spotting and 
development of the samples on the TLC plates. Cold Sty on the TLC 
plates was coloured by a ninhydrin reaction. The solvent system used 
for the TLC was as follows: first dimension. 1 -butanol/aceticacid/H,O 
(4: I:]): second dimension, phcnol/H,O (3: I, w/v) [I]. Occasionally. the 
activity in many enzyme fractions was measured by the analysis of 
hydrolyzates on one-dimensional TLC (solvent: I-butanohacetic acid/ 
H:O). The radioactivity of “Se on TLC was clarified by standard 
autoradiography. For quantitative measurement of radioactivity of 
“SC. silica on TLC plates was scraped and the radioactivity on the 
silica was determined by a y-autowell counter. 
3. RESULTS 
To search for the activity of Sty-tRNA synthesis, we 
first used the ‘H,Se mixture’ by Ganther [IS], as a Se 
donor. The mixture was composed of selenite, GSH, 
NADPH and GSH reductase. The analysis of the tRNA 
product revealed a weak spot of Sty when a supernatant 
at 8000 xg was used (data not shown). This supernatant 
at 8000 x g was centrifuged at 105 000 x g, and the 
activity was found in the superna.tant at 105 000 x g, as 
shown in Fig. 1 B. The precipitate at 105 000 x g did not 
contain any activity. as shown in Fig. 1A. These results 
show that the activity of Sty-tRNA synthesis is present 
in cytosol in the soIuble state. The fractions of micro- 
somes. mitochondria and nuclei did not contain any ac- 
tivity of Sty-tRNA synthesis. 
The spot of Sty on the TLC in Fig. I was not clear. 
By-products were smeared over all areas of the TLC 
plates. Therefore. we purified Hse- from the ‘H$e mix- 
ture’ by chromatography on Sephacryl S-200. as shown 
in Fig. 2. Two peaks were observed in the figure and 
were analyzed by TLC, as shown on the right in Fig. 2. 
The peaks in fractions 35-38 and 4146 were gluta- 
thione selenotrisulfide and HSe-. respectively [ 131. 
These two substances were studied as Se dol:ors in the 
synthesis of Sty-tRNA, as shown in Fig. 3. Fig. 3A 
showed that a clear Sty spot was found when HSe- and 
suppressor tRNA were used. Thus, HW was a good 
substrate. Glutathione selenotrisulfide was not a Se 
donor in the synthesis of Sty-tRNA. because there is no 
Sty spot denoted by the arrow in Fig. 3B. Fig. 3C 
denotes the case of major serine tRNA instead of 
suppressor tRNA: a [‘%e]Scy spot is not found at the 
position of the authentic Sty. These results show that 
HSe- and the suppressor tRNA were substrates in the 
synthesis of Sty- tRNA. but major serine tRNA and 
glutathione selenotrisuifide could not function as sub- 
strates. Sty-tRNA was precipitated by the addition of 
tube 
36 d3 I 
Q 
Fraction number (lml/tube) 
Fig. 2. Chromatographic pattern of ‘H:Se mixture’ on Sephacryl S-200, The fractions in tubes 35-38 and tubes 4146 wcrc analyzed by TLC. and 
autoradiograph of the TLC plate is shown at the right. 
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Fig. 3. Autoradiograph of the hydrolyzate of [“Se]aminoacyl-tRNA on silica gel G plates. Arrows indicate the position of cold Sty. The enzyme 
used was the supernatant at 105 000 x g. A, the product with suppressor tRNA and HSe-: B. the product with suppressor tRNA and glutathione 
selenotrisulfide; C, the product with major serinc tRNA and HSe-. 
ethanol, and Sty was found in the precipitate of tRNA. 
We also analyzed the supernatant of ethanol precipita- 
tion, but the supernatant did not contain any Sty. This 
revealed that free Sty was neither synthesized in the 
reaction mixture nor directly transferred to the suppres- 
sor tRNA by some aminoacyl-tRNA synthetase. 
Fig. 1 shows that he Sty synthase is present in cyto- 
sol. The supernatant at 105000 x g also contains all 
soluble components, such as tRNA and enzymes. 
Therefore, we attempted the separation of the Sty 
synthase from the tRNA by chromatography. The 
upper portion of Fig. 4 shows an elution pattern of the 
supernatant on DEAE-cellulose. SerRS activity was 
found at tube 33. The activity of the Sty synthase was 
searched for in those eluated fractions and was found 
in fractions 30- 32, as shown in the lower section of Fig. 
4. The lower section of Fig. 4 indicates the results of 
autoradiography of [“Se]Scy on a TLC plate. The rela- 
tive values of the densitometric tracing of autoradiog- 
raphy were plotted in the upper section of Fig. 4. The 
Sty synthase was eluted at a slightly lower concentra- 
tion of KC1 (0.17 M) than SerRS (0.20 M). The peak of 
tRNA kinase was eluted at a higher concentration of 
KC1 than was the SerRS. This showed that the Sty 
synthase differed from SerRS and tRNA kinase. This 
fraction (tubes 30-32 in Fig. 4) contained a trace 
amount of SerRS but did not contain any tRNA kinase 
activity (data not shown). The fraction without tRNA 
kinase exhibited activity with which to synthesize Scy- 
tRNA. This is a key point of this report, because this 
result shows that Ps-tRNA was not an intermediate in 
the synthesis of Sty-tRNA. It had been incorrectly con- 
sidered that Ps-tRNA was an active intermediate in the 
synthesis of Sty-tRNA; however, this misunderstanding 
must now be abandoned. This Sty synthase activity was 
stable during long-time storage in 50% glycerol. 10 mM 
Tris-HCl. 10 mM MgCI,. 10 mM mercaptoethanol at 
-80°C. 
Sty was found in the tRNA precipitate with ethanol, 
but was not found in the supernatant. Therefore, Sty is 
bound to tRNA, as was confirmed by gel chroma- 
tography on Sephacryl S-200. The precipitate by 
ethanol was applied to the column. The result is shown 
in Fig. 5. A peak of ‘?Se (tubes 15-19) was found coin- 
cidentally with the position of the tRNA. The radioac- 
tivity in the peak was confirmed to be from Sty by TLC 
(data not shown). Thus, we showed that mammalian 
cells contained the activity of Sty-tRNA synthesis in 
cytosol and that the Se donor in the synthesis of Scy- 
tRNA in HSe-. This HSe- may be activated by ATP and 
then transferred to the Ser-tRNA-enzyme complex to 
become Sty- tRNA. as in the E. coli system. 
4 
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Fig. 4. Chromatograph of the supernatant of murine liver extracts at 
10.5 000 x g on DEAE-cellulose. The upper section is a chromato- 
graphic profile on DEAE-cellulose. Open circles indicate the density 
of Sty on the lower autoradiograph. Closed circles indicate SerRS 
activity (cpm/5 min.S ~1). The lower section is an autoradiograph of 
Sty liberated from Sty-tRNA produced with the upper eluates as 
enzyme sources. Arrows indicate the position of Sty. 
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Fig. 5. Chromatographic pattern of the aminoacyl-tRNA precipitate 
on Sephacryl S-200. The ethanol precipitate of [75Se]Scy-tRNA from 
the reaction mixture was applied to a column of Sephacryl S-200 in 
0.15 M NaCI. IO mM acetate at pH 4.6. 
4. DISCUSSION 
Suppressor seryl-tRNA was phosphorylated by 
tRNA kinase to Ps-tRNA [15]. Suppressor seryl-tRNA 
is a substrate of this phosphorylation. We purified 
tRNA kinase from bovine liver [7], and the amount of 
Ps-tRNA was 5% of the total seryl-tRNA by in vitro 
phosphorylation [9]. It is therefore considered that this 
Ps-tRNA must play an important role in cells. This 
Ps-tRNA was not a substrate for phosphoserine amino- 
transferase [16]. Since suppressor seryl-tRNA was a 
precursor of Sty-tRNA. it was considered that Ps- 
tRNA was an intermediate substance in the process 
from seryl-tRNA to Sty-tRNA [5,8]. In the previous 
report [9]. we misunderstood Ps-tRNA to be an inter- 
mediate, because Sty-tRNA was synthesized in the 
presence of ATP from seryl-tRNA. However. in this 
report, we have shown that Sty-tRNA was synthesized 
from seryl-tRNA in the absence of tRNA kinase; there- 
fore, Ps-tRNA is not an intermediate between seryl- 
tRNA and Sty-tRNA. ATP should be necessary at an 
unknown step in order to synthesize Sty-tRNA. Thus, 
it is concluded that Sty-tRNA synthesis proceeds ac- 
cording to the same mechanism as that in E. coli. 
In E. coli there are four genes (&A, B, C and D) 
relating to the synthesis of FDH. The product of se/C 
is a suppressor tRNA for Sty [ 171. The product of selB 
is a translation factor (like EF-Tu) specific to Sty-tRNA 
[ 181. The product of seiA is a Sty synthase. and .selD 
plays a role in bringing HSe-. to the Ser-tRNA-SELA 
complex with ATP [IO]. The activity in the DEAE frac- 
tion in Fig. 4 may contain these two activities, similar 
to SELA and SELD in E. co/i. In the ?clture we will 
attempt to separate these two activities. A new question 
about the roles of Ps-tRNA and tRNh kinase thus 
arises. We expect that, in the future, the UGA codon 
corresponding to phosphoserine will be found in some 
mRNAs of important proteins. 
Se is an essential trace element in humans [l9]. We 
ingest Se as SeO, from food and water (the organic 
compound is converted to SeO, by digestion). SeO, is 
converted to HSe- in the cytosol. where the reductive- 
type GSH is abundant [20]. HSe- is used as a Se donor 
and may be incorporated into Sty-tRNA after activa- 
tion. In our bodies, the concentration of Se is 0.2 ppm 
(2.5 PM). More Se is present in a bound state on prote- 
ins and free Se may comprise approximately one-tenth 
of 2.5 PM. The concentration of HSe- used in this ex- 
periment was 0.1 PM, near the above value of the nat- 
ural free-HSe- concentration. Therefore. the conditions 
in this experiment are natural and similar to those in cell 
cytosol. 
The mechanisms of Sty-tRNA synthesis in mammals 
are the same as those in E. co/i. In eukaryotes and 
prokaryotes, there is a natural opal suppressor tRNA 
specific for Sty. This tRNA is aminoacylated with se- 
rine, and then Ser-tRNA is converted to Sty-tRNA by 
some enzymes in common mechanisms. There may be 
a translation factor (antireleasing factor) specific for 
Sty-tRNA in mammals, similar to SELB in E. coli [I 81. 
This factor transports Sty-tRNA to ribosomes, and Sty 
on Sty-tRNA is co-translationally transferred to pep- 
tides on ribosomes. Thus, eukaryotes and prokaryotes 
must have a common Sty translating mechanism. 
However, the structure of Sty tRNA differs between 
mammals and E. coli, as do the differences between 
other tRNAs specific for each amino acid. Proteins also 
differ amongst themselves (GSHPx and type-1 iodothy- 
ronine deiodinase in eukaryotes; FDH in E. coli; glycine 
reductase in Closrridiut~t sticklandii) [8]. Another inter- 
esting difference between eukaryotes and prokaryotes 
involves the secondary structure of mRNA (context 
effect). The region downstream of the UGA in FDH 
mRNA forms a specific secondary structure in order 
to incorporate Sty into FDH on the translational 
level [21]. However, no common secondary struc- 
ture downstream of the UGA (Sty codon) among 
some GSHPx mRNAs and type-1 iodothyronine deiodi- 
nase mRNA can be pinpointed by a computer search. 
Mechanisms of discrimination between the Sty codon 
UGA and the opal termination codon UGA are not 
clear; thus, this is a very interesting mystery yet to be 
resolved. 
Aminoacyl-tRNA synthetase arose early in evolution 
and is the oldest of all proteins [22]. However, GSHPx 
is also an old enzyme, judging from its simple amino 
acid composition [23]. Thus, the system of Sty incorpo- 
ration might have had an extensive role in the early 
stages of the reductive atmosphere of the earth. The 
UGA codon might not have been a termination codon, 
but rather a Sty codon in that early stage of the earth. 
The role of the UGA codon may have changed to that 
of a termination codon after the stage of the oxidative 
atmosphere of the earth. According to evolutionary the- 
ories? the use of UGA as a termination codon was in- 
creased because UGA comprises 50% of the total 
termination codons in mammals and 27% in E. coli. 
Thus, the pairing of Sty-tRNA and certain seleno- 
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proteins is essential to sustain life in mammals and E. 
coli at present, but may be come a vestigial remnant in 
the translation system. 
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